Trials / Completed
CompletedNCT01220115
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 498 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
A long term observational study in sickle cell disease will enhance the understanding of the disease patterns, current transfusion practices, treatments and outcomes in sickle cell disease.
Conditions
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2010-10-13
- Last updated
- 2019-12-09
Locations
42 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01220115. Inclusion in this directory is not an endorsement.